期刊文献+

艾司佐匹克隆对健康受试者血压的影响 被引量:1

The influence of eszopiclone treatment on blood pressure in healthy volunteers
下载PDF
导出
摘要 目的:分析单次口服艾司佐匹克隆对健康受试者血压的影响。方法:选择18~45岁之间的健康受试者26例,随机分为1.8,3.75,7.5,11.25和15.0 mg共5个剂量组。对服药后1,4,8 h的血压进行监测和24 h,7 d随访。结果:受试者的血压在服药后呈下降趋势,服药后各时间点的血压与服药前比较差异均有显著性统计学差异(P<0.05);最大下降幅度为25 mmHg。血压降低较明显者主要集中在服药后1~4 h。11例(42.3%)受试者出现收缩压或舒张压下降>20%的情况,11.25~15 mg剂量组发生率为58.3%(7/12),高于较低剂量组的发生率(28.6%,4/14)。在11.25~15 mg剂量组,有3例血压降低>20%的受试者出现了“头晕”的不良反应。结论:应关注艾司佐匹克隆对血压的潜在影响。 Objective:To analyze the effect of single dose eszopiclone treatment on blood pressure in healthy volunteers. Methods:Twenty-six subjects were involved in the study. They were randomized into 5 subgroups with eszopiclone dosage 1.8 mg, 3.75 mg, 7.5 mg, 11.25 mg and 15.0 mg. The blood pressures were measured at 1 h,4 h, 8 h,24 h and 7 d after eszopiclone treatment. Results:The blood pressures were decreased statistically significantly ( P 〈 0.05 ). It happened at 1 h and 4 h after treatment. There were 11 subjects (42.3 % ) whose decreased rate of systolic or diastolic blood pressure were up to 20%, and the incidence in 11.25 mg - 15.0mg subgroup (58.3% ,7/12) were higher than that of in the low-dose subgroup ( 28. 6% ,4/14). Three of these subjects in 11.25 mg ~ 15.0 mg had the adverse reaction of dizziness. Conclusion : More attention should be paid to the possible effects of eszopiclone on blood pressure.
出处 《中国新药杂志》 CAS CSCD 北大核心 2007年第11期886-889,共4页 Chinese Journal of New Drugs
关键词 艾司佐匹克隆 血压 不良反应 eszopiclone blood pressure adverse reaction
  • 相关文献

参考文献11

  • 1GRAY KZ,LOUIS JM,JUDY C,et al.Efficacy and safety of eszopiclone across 6-weeks of treatment for primary insomnia[J].Curt Med Res Opin,2004,20(12):1979-1991.
  • 2ROSENBERG R,CARON J,ROTH T,et al.An assessment of the efficacy and safety of eszopiclone in the treatment of transient insomnia in healthy aduhs[J].Sleep Med,2005,6(1):15-22.
  • 3刘琦,张鸿燕,阮晶,李华芳,李静,程焱,张微微.国产艾司佐匹克隆治疗失眠症的对照研究[J].中国新药杂志,2006,15(8):633-636. 被引量:20
  • 4张鸿燕,原岩波,黄兰,李玲芝,舒良.右旋佐匹克隆I期耐受性试验[J].中国临床药理学杂志,2004,20(4):258-260. 被引量:19
  • 5NOBLE S,LANGTRY HD,LAMB HM.Zopiclone An update of its pharmacology,clinical efficacy and tolerability in the treatment of insomnia[J].Drugs,1998,55(2):277-302.
  • 6WAGNER J,WAGNER ML.Non-benzodiazepines for the treatment of insomnia[J].Sleep Med Rev,2000,4(6):551-581.
  • 7DAVIES M,NEWLL JG,DERRY JM,et al.Characterization of the interaction of Zopiclone with γ-Aminobutyric acid type A receptors[J].Mol Pharmacol,2000,58(4):756-762.
  • 8CARLSON JN,HASKEW R,WACKER J,et al.Sedative and anxiolytic effects of zopiclone's enantiomers and metabolite[J].Eur J Pharmacol,2001,415(2-3):181-189.
  • 9KRYSTAL AD,WALSH JK,LASKA E,et al.Sustained efficacy of eszopiclone over six months of nightly treatment:Results of a randomized,double-blind,placebo controlled study in adults with chronic insomnia[J].Sleep,2003,26(7):793-799.
  • 10ROTH T,WALSH JK,KRYSTAL A,et al.An evaluation of the efficacy and safety of eszopiclone over 12 months in patients with chronic primary insomnia[J].Sleep Med,2005,6(6):487-495.

二级参考文献18

  • 1张鸿燕,原岩波,黄兰,李玲芝,舒良.右旋佐匹克隆I期耐受性试验[J].中国临床药理学杂志,2004,20(4):258-260. 被引量:19
  • 2Terzano MG,Rossi M,Palomba V,et al.New drugs for insomnia:comparative tolerability of zopiclone,zolpidem and zaleplon[J].Drug Saf,2003; 26:261-282.
  • 3Lader M,Denney SC.A double-blind study to establish the residual effects of zopiclone on performance in healthy volunteers[J].Pharmacology,1983;27 (Suppl.2):S98-S108.
  • 4Wadworth AN,Mctavish D.Zopiclone.A review of its pharmacological properties and therapeutic efficacy as an hypnotic[J].Drugs Aging,1993;3:441-459.
  • 5Wiegand MH,Roszinsky-Kocher G,Schwalb B,et al.Effectiveness of zopiclone in disorders of initiating and maintaining sleep.Results of a drug monitoring study in 811 general practices[J].Fortschr Med Orig,2001;119:25-32.
  • 6Hajak G.A comparative assessment of the risks and benefits of zopiclone:a review of 15 years' clinical experience[J].Drug Saf,1999;21:457-469.
  • 7Noble S,Langtry HD,Lamb HM.Zopiclone.An update of its pharmacology,clinical efficacy and tolerability in the treatment of insomnia[J].Drugs.1998;55:277-302.
  • 8Ranlov P J,Nielsen SP.Effect of zopiclone and diazepam on ventilatory response in normal human subjects[J].Sleep,1987; 10(Suppl.1):S40-S47.
  • 9Mattila ME,Mattila M J,Nuotto E.Caffeine moderately antagonizes the effects of triazolam and zopiclone on the psychomotor performance of healthy subjects[J].Pharrnacol Toxicol,1992; 70:286-289.
  • 10Blaschke G,Hempel G.Preparative and analytical separation of the zopiclone enantimers and determination of their affinity to the benzodiazepine receptor binding site[J].Chirality,1993;5:419-421.

共引文献39

同被引文献9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部